Biogen’s Skyclarys (omaveloxolone) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as the ...

An urgent warning has been issued to asthma sufferers over the use of a vital treatment to relieve their symptoms. There are ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...

It has issued a reminder to sufferers of the importance of using their preventer (anti-inflammatory) inhaler regularly as ...

As with all products, we will keep its safety under close review. The Medicines and Healthcare products Regulatory Agency ...

Lercanidipine HCl 20mg Tablets, a drug that is consumed by adults for hypertension, was recalled by the UK's MHRA over the ...

Pfizer’s Hympavzi (marstacimab) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...

Biogen Netherlands has received marketing authorisation from the UK MHRA for its Skyclarys to treat Friedreich's ataxia.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) claims the UK is again a global leader in clinical trials.

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding patients with asthma of the importance of using ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...